Skip to main content
Figure 3 | Arthritis Research & Therapy

Figure 3

From: Expanding the armamentarium for the spondyloarthropathies

Figure 3

Percentage of patients treated with placebo, infliximab, or placebo followed by infliximab responding to therapy in the double-blind and open-label phases of the study. The results are from an intention-to-treat analysis. Reproduced with permission from John Wiley & Sons, Inc. [56]. © 2002 American College of Rheumatology

Back to article page